欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Cholecystokinin Receptor

Cholecystokinin Receptor

货号 产品名 CAS号 信息
CSN26386 YM022 145084-28-2 YM022 is a highly potent, selective and orally active gastrin/cholecystokinin (CCK)-B receptor (CCK-BR) antagonist. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively[1]. YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo[3].
CSN22510 Sograzepide 155488-25-8 Sograzepide is a gastrin/cholecystokinin 2 receptor (CCK2) antagonist.
CSN23839 Proglumide 6620-60-6 Proglumide is a known cholecystokinin (CCK) antagonist.
CSN18099 Nastorazepide 209219-38-5 Nastorazepide is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
CSN21716 Loxiglumide 107097-80-3 Loxiglumide is a cholecystokinin (CCK) receptor antagonist.
CSN22513 SR 146131 221671-61-0 GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity.
CSN22411 GI 181771 305366-98-7 GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity.
CSN21655 Gastrin-1, human 10047-33-3 Gastrin I is an endogenous gastrointestinal peptide hormone that can bind to cholecystokinin (CCK) receptors.
CSN26412 Devazepide 103420-77-5 Devazepide is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide is effective for gastrointestinal disorders[1].
<< PREV 1 NEXT >>
联系
我们